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significantly reduced cytokine-stimulated NO production byInhibition of inducible nitric oxide synthase reduces renal ische-
primary cultures of rat PT cells in a dose-dependent manner.mia/reperfusion injury.
Conclusions. These results suggest that L-NIL and AE-ITUBackground. Nitric oxide (NO), produced via inducible ni-
reduce the renal dysfunction and injury associated with I/R oftric oxide synthase (iNOS), is implicated in the pathophysi-
the kidney, via inhibition of iNOS activity and subsequent re-ology of renal ischemia/reperfusion (I/R) injury. The aim of
duction of NO (and peroxynitrite) generation. We proposethis study was to investigate the effects of the iNOS inhibitors
that selective and specific inhibitors of iNOS activity may beL-N6-(1-iminoethyl)lysine (L-NIL) and aminoethyl-isothiourea
useful against the NO-mediated renal dysfunction and injury(AE-ITU) on (a) renal dysfunction and injury mediated by bi-
associated with I/R of the kidney.lateral I/R of rat kidneys in vivo and (b) cytokine-stimulated
NO production by primary cultures of rat proximal tubule
(PT) cells.
Methods. Male Wistar rats subjected to bilateral renal ische- Despite significant advances in critical care medicine,
mia (45 min) followed by reperfusion (6 h). Rats were admin-
acute renal failure (ARF) remains a major clinical prob-istered either L-NIL (3 mg/kg IV bolus 15 min prior to I/R fol-
lem, and mortality associated with ARF has not decreasedlowed by 1 mg/kg/h throughout I/R) or AE-ITU (1 mg/kg IV
bolus 15 min prior to I/R followed by 1 mg/kg/h throughout substantially over the last 50 years [1, 2]. The mortality
I/R). Serum and urinary biochemical indicators of renal dys- rate of ARF remains between 50 to 70% among patients
function and injury were measured; serum creatinine (SCr, glo- in intensive care who require dialysis, and ranges be-
merular dysfunction), fractional excretion of Na (FENa, tubu- tween 25 and 100% in post-operative patients sufferinglar dysfunction), serum aspartate aminotransferase (sAST, I/R
ARF [3–5]. Additionally, ARF is frequently implicated ininjury) and urinary N-acetyl--d-glucosaminidase (uNAG, tu-
bular injury). Additionally, renal sections were used for histo- the pathophysiology of other life-threatening complica-
logical grading of renal injury and for immunological evidence tions including sepsis and multiple-organ failure (MOF)
of nitrotyrosine formation. Nitrate/nitrate levels in plasma were [6, 7]. Renal ischemia is a major cause of ARF, initiating
measured using the Griess assay and used as an indicator of
a complex and interrelated sequence of events, resultingNO production. Primary cultures of rat PT cells were incubated
in injury to, and the eventual death of renal cells [1, 8].with interferon- (IFN-, 100 IU/mL) and lipopolysaccharide
The prognosis is complicated by the fact that reperfusion,(LPS, 10 g/mL) for 24 h, either in the absence or presence
of increasing concentrations of L-NIL or AE-ITU (0.001 to 1 although essential for the survival of ischemic renal tis-
mmol/L) after which nitrite/nitrate levels were measured using sue, causes additional damage (reperfusion-injury) [9],
the Griess assay. contributing to the renal dysfunction and injury associ-Results. L-NIL and AE-ITU significantly reduced the I/R-
ated with ischemia/reperfusion (I/R) of the kidney [1, 8,mediated increases in SCr, FENa, sAST and uNAG, indicating
9]. Furthermore, it appears that the proximal tubule (PT)attenuation of I/R-mediated renal dysfunction and injury. Spe-
cifically, L-NIL and AE-ITU reduced the I/R-mediated glo- is particularly susceptible to injury caused by renal I/R
merular and tubular dysfunction and biochemical and histo- [10, 11]. Subsequent to renal transplantation, renal I/R is
logical evidence of tubular injury. Both L-NIL and AE-ITU also a major cause of early allograft rejection and ad-attenuated the plasma levels of nitrate (indicating reduced
versely affects the long-term survival of the allograft [12].NO production) and the immunohistochemical evidence of the
Thus, motivated by the fact that previous interventionsformation of nitrotyrosine. In vitro, L-NIL and AE-ITU both
against ARF have proved to be largely ineffective and that
dialysis still remains the only effective therapy [2], devel-
Key words: kidney, dysfunction, iNOS inhibitors, L-NIL, AE-ITU, rat. opment of novel therapeutic interventions with which to
reduce renal dysfunction and injury mediated by I/R of 2002 by the International Society of Nephrology
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the kidney, and associated ARF, have been topics of ischemia for 45 minutes followed by reperfusion for six
hours (N  10).intense research interest.
Nitric oxide (NO), generated by any one of the three I/R L-NIL group. Animals were administered L-NIL
(3 mg/kg IV) 15 minutes prior to I/R followed by infu-isoforms of nitric oxide synthase (NOS) plays an impor-
tant role in renal function, both under normal and patho- sion (1 mg/kg/h, IV) throughout the reperfusion period
(N  9).physiological conditions [13, 14]. All three isoforms of
NOS have been located in the kidney; the endothelial I/R AE-ITU group. Animals were administered AE-
ITU (1 mg/kg IV) 15 minutes prior to I/R followed byand neuronal (constitutive) isoforms have been identi-
fied in the renal vasculature and macula densa, respec- infusion (1 mg/kg/h, IV) throughout the reperfusion pe-
riod (N  8).tively [15] and inducible NOS (iNOS) can be induced in
the kidney by cytokines, lipopolysaccharide and during Sham Control group. Sham-operated rats were sub-
jected to identical surgical procedures described aboveI/R [15–17] leading to renal cell injury [18]. Several in
vivo and in vitro investigations have demonstrated how except for renal I/R and maintained under anesthesia for
the duration of the experiment (45 min  6 h, N  12).inhibition of the expression or activity of iNOS, or ab-
sence of iNOS itself, can ameliorate or prevent renal I/R Sham L-NIL group. These animals were identical to
Sham-operated animals except for treatment with L-NILinjury [19–23], suggesting that NO generated by iNOS
contributes to renal I/R injury. as described above (N  4).
Sham AE-ITU group. They were identical to Sham-Furthermore, it is now clear that the production of re-
active oxygen species (ROS) such as hydrogen peroxide, operated animals except for treatment with AE-ITU as
described above (N  4).superoxide and hydroxyl radicals contribute to renal I/R
injury (and associated ARF) [9, 11]. Traditionally, ROS Rats in the Sham and I/R Control groups received an
IV bolus of saline and infusion throughout I/R at thehave been considered to exert their effects through a di-
rect toxic action on target cells. For example, ROS cause same rate as that administered to the L-NIL and AE-
ITU group.DNA damage during renal I/R and oxidative stress [24–26]
leading to the activation of the nuclear enzyme poly
Measurement of biochemical parameters(ADP-ribose) polymerase (PARP), depletion of NAD
and adenosine 5-triphosphate (ATP) and ultimately cell At the end of the reperfusion period, blood (1 mL)
samples and urine samples were collected and used fordeath [25, 26]. Thus, various antioxidant strategies such
as the use of TEMPOL or desferrioxamine have been the measurement of biochemical renal parameters as
described previously [22, 26, 27]. Briefly, serum samplesshown to provide beneficial actions against renal dys-
function and injury mediated by I/R of the kidney [27]. were used for the measurement of serum urea (SUr) and
creatinine (SCr) levels, which were used as indicators ofFurthermore, NO reacts with superoxide anion to form
peroxynitrite [28], which causes injury via direct oxidant impaired glomerular function [22, 26, 27], and aspartate
aminotransferase (AST), which was used as an indicatorinjury and protein tyrosine nitration [28, 29]. Specifically
in the kidney, peroxynitrite generation has been impli- of renal I/R injury [22, 27]. Urine samples were collected
during the reperfusion period and the volume of urine pro-cated in the pathophysiology both renal I/R and hypoxia-
reoxygenation injury, respectively [18, 30, 31]. duced recorded. Urine concentrations of creatinine were
measured and used in conjunction with SCr and urineHere we compare the effects L-N6-(1-iminoethyl)lysine
(L-NIL) and aminoethyl-isothiourea (AE-ITU), both flow to estimate the glomerular filtration rate in the form
of creatinine clearance (CCr), which was used as an indica-relatively selective inhibitors of iNOS activity [32–34] on
(a) renal dysfunction and injury in an in vivo model of tor of glomerular function [22, 26, 27]. In a similar fash-
ion, urinary and serum concentrations of Na were mea-renal I/R injury and (b) cytokine-stimulated NO produc-
tion by primary cultures of rat PT cells. sured and used in conjunction with urine flow to calculate
fractional excretion of Na (FENa), which was used as an
indicator of tubular dysfunction [22, 26, 27]. Addition-
METHODS
ally, concentrations of urinary N-acetyl--d-glucosamini-
Renal ischemia/reperfusion dase (NAG), an indicator of tubular damage, and possi-
bly tubular function, were measured (Dr. Joaquim Chaves,In vivo studies were carried out using 47 male Wistar
rats (Tuck, Rayleigh, Essex, UK) weighing 215 to 330 g. Clinica Medica e Diagnostico, Lisbon, Portugal; personal
communication) [22, 27].Rats were subjected to renal bilateral renal ischemia
for 45 minutes followed by reperfusion for six hours as
Measurement of plasma nitrite/nitrate concentrationsdescribed previously [22, 26, 27]. Upon completion of
surgical procedures, the animals were randomly allo- Nitrite and nitrate are the primary oxidation products
of NO subsequent to reaction with oxygen and, there-cated into six groups:
I/R Control group. Control animals underwent renal fore, the nitrite/nitrate concentration in plasma was used
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as an indicator of NO synthesis. Nitrite/nitrate levels in bacterial lipopolysaccharide (LPS) in combination in the
absence or presence of increasing concentrations of L-NILrat plasma were measured as previously described [35]
after enzymatic conversion of nitrate to nitrite using ni- (0.001 to 1 mmol/L) or AE-ITU (0.001 to 1 mmol/L) for
24 hours. Upon completion of incubations, NO levels intrate reductase. Subsequently, total nitrite in the plasma
was assayed by adding 100 L Griess reagent (0.05% incubation medium was measured as nitrite/nitrate after
conversion of nitrate to nitrite using nitrate reductase as(wt/vol) naphthalethylenediamine dihydrochloride and
0.5% (wt/vol) sulphanilamide in 2.5% (vol/vol) phosphoric described above and previously [35].
acid) to each sample. Optical density at 550 nm (OD550)
Materialswas measured (Molecular Devices microplate reader,
Richmond, CA, USA) and total nitrite/nitrate concen- Unless otherwise stated, all compounds used in this
study were purchased from Sigma-Aldrich Companytration for each sample was calculated by comparison of
the OD550 of a standard solution of sodium nitrate (also Ltd. (Poole, Dorset, UK). LPS was obtained from E. coli
serotype 0.127:B8 (Sigma).stoichiometrically converted to nitrite) prepared in saline.
All solutions used for in vivo infusions were prepared
Histological evaluation using non-pyrogenic saline [0.9% (wt/vol) NaCl; Baxter
Healthcare Ltd., Norfolk, UK].Renal sections were prepared as described previously
and used for the assessment of renal I/R injury [23, 27].
Statistical analysisBriefly, 100 intersections were examined for each kidney
and a score from 0 to 3 was given for each tubular profile All values described in the text and figures are ex-
pressed as mean  standard error (SE) of the mean forinvolving an intersection: 0  normal histology; 1 
tubular cell swelling, brush border loss, nuclear conden- the number (N) of observations. For in vivo studies and
histological scoring, each data point represents biochem-sation, with up to 1/3 of tubular profile showing nuclear
loss; 2  as for score 1, but greater than 1/3 and less ical measurements obtained from N separate animals.
For immunohistochemical analysis, the figures shown arethan 2/3 of tubular profile shows nuclear loss; and 3 
greater than 2/3 of tubular profile shows nuclear loss. The representative of at least three experiments performed
on different experimental days. For in vitro studies in-total score for each kidney was calculated by addition of
all 100 scores with a maximum score of 300. volving PT cell cultures, measurements were taken from
cultures obtained from 12 separate isolations from 12
Immunohistochemical localization of nitrotyrosine separate animals. For the determination of NO produc-
tion (Griess assays performed on from rat plasma andTyrosine nitration, which was used as an index of the
nitrosylation of protein by peroxynitrite and/or ROS, incubation medium from PT cells), experiments were
performed in triplicate. Statistical analysis was carriedwas determined using immunohistochemistry as previ-
ously described [27]. Briefly, sections were incubated over- out using GraphPad Prism/Instat 1.1 (GraphPad Soft-
ware, San Diego, CA, USA). Data were analyzed usingnight with a 1:1000 dilution of primary anti-nitrotyrosine
monoclonal antibody (DBA, Milan, Italy). Separate sec- one-way ANOVA followed by Bonferroni’s post hoc
test and a P value of less than 0.05 was considered totions were also incubated with control solutions consist-
ing of PBS alone or a 1:500 dilution of non-specific puri- be significant (NS  not significant).
fied rabbit IgG (DBA). Specific labeling was detected
using a biotin-conjugated goat anti-rabbit IgG (DBA)
RESULTS
and avidin-biotin peroxidase (DBA). Samples were then
Effect of L-NIL and AE-ITU on ischemia/viewed under a light microscope.
reperfusion-mediated glomerular dysfunction
Isolation and culture of rat proximal tubular cells Animals that underwent renal I/R exhibited significant
increases in the serum concentrations of creatinine com-Proximal tubule cells were isolated from kidneys ob-
tained from 12 male Wistar rats (260 to 350 g) using colla- pared to Sham-operated animals (Fig. 1), suggesting a
significant degree of glomerular dysfunction. This wasgenase digestion, differential sieving and Percoll density
centrifugation as described previously [25, 27]. Rat PT reflected by a significant increase in serum levels of urea
[from 6  0.4 mol/L (Sham-operated group) to 24 cells were cultured in minimum essential medium (MEM)
containing 10% (vol/vol) FCS in a humidified 5% CO2/ 1 mol/L (I/R only group), P  0.05], also indicating
glomerular dysfunction mediated by renal I/R. Renal I/R95% air atmosphere at 37	C and medium was changed
every 48 hours until the cells reached confluence. also produced a significant reduction in CCr [from 1.1 
0.2 mL/min (Sham-operated group) to 0.013 0.005 mL/
Experimental design min (I/R only group), P  0.05], which was used as an
indicator of glomerular filtration rate and thus, glomeru-Confluent primary cultures of rat PT cells were incu-
bated with 100 IU/mL interferon- (IFN-) and 10g/mL lar function.
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Fig. 2. Effect of renal I/R on fractional excretion of Na (FENa) in theFig. 1. Alterations in serum creatinine concentrations during renal
presence of L-NIL (3 mg/kg IV bolus followed by 1 mg/kg/h IV infus-ischemia/reperfusion (I/R) in the presence of L-NIL (3 mg/kg IV bolus
ion), or AE-ITU (1 mg/kg IV bolus followed by 1 mg/kg/h IV infusion).followed by 1 mg/kg/h IV infusion), or AE-ITU (1 mg/kg IV bolus fol-
*P  0.05 vs. sham-operated group, P  0.05 vs. I/R only group.lowed by 1 mg/kg/h IV infusion). *P  0.05 vs. sham-operated group,
P  0.05 vs. I/R only group.
Treatment of rats with L-NIL prior to and throughout
I/R produced a relatively small, but significant, reduction
in the serum levels of creatinine (Fig. 1). Administration
of AE-ITU prior to and during I/R had a similar, signifi-
cant effect on I/R-mediated increases in serum creatinine
levels (Fig. 1).
Administration of L-NIL or AE-ITU prior to and
throughout I/R produced a similar significant attenua-
tion of I/R-mediated increase in serum urea [from 24 
1 mol/L (I/R only group) to 19  2 mol/L (I/R 
L-NIL group), P  0.05 vs. I/R only group, and 21  1
mol/L (I/R  AE-ITU group), P  0.05 vs. I/R only
group]. Administration of L-NIL or AE-ITU prior to
and throughout I/R also produced a significant increase
in the reduced CCr associated with renal I/R [from 0.013 Fig. 3. Alterations in urinary N-acetyl--D-glucosaminidase levels dur-
ing renal I/R, in the presence of L-NIL (3 mg/kg IV bolus followed by0.005 mL/min (I/R only group) to 0.73  0.13 mL/min
1 mg/kg/h IV infusion), or AE-ITU (1 mg/kg IV bolus followed by(I/R  L-NIL group), P  0.05 vs. I/R only group, and 1 mg/kg/h IV infusion). *P  0.05 vs. sham-operated group, P  0.05
1.10  0.12 mL/min (I/R  AE-ITU group), P  0.05 vs. I/R only group.
vs. I/R only group].
Administration L-NIL or AE-ITU to Sham-operated
rats did not result in any alteration in serum levels of tion with urine production (urine flow, mL/min), was
creatinine on comparison to Sham-operated rats that used as an indicator of tubular function. I/R produced
were administered saline only (Fig. 1). Similarly, admin- a significant increase in FENa suggesting tubular dysfunc-
istration L-NIL or AE-ITU to Sham-operated rats did tion (Fig. 2). Administration of L-NIL or AE-ITU prior
not result in any alteration in serum urea levels or in to and during I/R produced a reduction in the I/R-medi-
CCr on comparison to Sham-operated rats, which were ated increase in FENa, suggesting improvement in tubular
administered saline only (data not shown). function (Fig. 2). Administration of L-NIL or AE-ITU
to Sham-operated rats did not alter FENa on comparison
Effect of L-NIL and AE-ITU on ischemia/ to values obtained from Sham-operated rats that were
reperfusion-mediated tubular dysfunction/injury administered saline only (Fig. 2).
Fractional excretion of sodium (FENa), calculated us- Renal I/R produced a significant increase in the uri-
nary concentrations of NAG (Fig. 3), suggesting signifi-ing plasma and urinary concentrations of Na in associa-
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Fig. 4. Effect of renal I/R on serum aspartate aminotransferase concen- Fig. 5. Effect of renal I/R on the total severity score in the presence
trations during renal I/R in the presence of L-NIL (3 mg/kg IV bolus of L-NIL (3 mg/kg IV bolus followed by 1 mg/kg/h IV infusion), or
followed by 1 mg/kg/h IV infusion), or AE-ITU (1 mg/kg IV bolus fol- AE-ITU (1 mg/kg IV bolus followed by 1 mg/kg/h IV infusion). *P 
lowed by 1 mg/kg/h IV infusion). *P  0.05 vs. sham-operated group, 0.05 vs. sham-operated group, P  0.05 vs. I/R only group.
P  0.05 vs. I/R only group.
cant tubular injury. Administration of L-NIL or AE-ITU
prior to and during I/R significantly reduced I/R-medi-
ated increase in urinary NAG, suggesting attenuation of
tubular injury (Fig. 3). Administration of L-NIL or AE-
ITU to Sham-operated rats did not alter NAG concentra-
tions on comparison to values obtained from Sham-oper-
ated rats, which were administered saline only (Fig. 3).
Effect of L-NIL and AE-ITU on ischemia/
reperfusion injury
Renal I/R produced a significant increase in the serum
concentrations of AST on comparison with values obtained
from Sham-operated animals (Fig. 4). Serum concentra-
tions of AST, which was used as marker of I/R-injury,
was significantly reduced subsequent to administration
Fig. 6. Effect of L-NIL and AE-ITU on NO2/NO3 production mediatedof L-NIL or AE-ITU prior to and during I/R (Fig. 4).
by renal I/R; L-NIL was administered at 3 mg/kg IV bolus followed byAdministration of L-NIL or AE-ITU to Sham-operated
1 mg/kg/h IV infusion. AE-ITU was administered at 1 mg/kg IV bolus
rats did not alter serum concentrations of AST in com- followed by 1 mg/kg/h IV infusion. *P  0.05 vs. sham-operated group,
P  0.05 vs. I/R only group.parison to values obtained from Sham-operated rats that
were administered saline only (Fig. 4).
Effects of L-NIL and AE-ITU on ischemia/
Effect of L-NIL and AE-ITU on ischemia/reperfusion-mediated renal histopathology
reperfusion-mediated increase in plasmaWhen compared to the total severity score measured
nitrite/nitrate levelsfrom kidneys obtained from Sham-operated animals, re-
Renal I/R resulted in a significant increase in the plasmanal I/R produced a significant increase in total severity
levels of nitrite/nitrate on comparison with values obtainedscore, indicating significant tubular injury (Fig. 5). Total
from the plasma of Sham-operated animals (Fig. 6). In-severity scores were significantly reduced by administra-
creased plasma nitrite/nitrate levels mediated by renaltion of L-NIL or AE-ITU prior to and during I/R (Fig. 5).
I/R were significantly reduced after administration ofAdministration of L-NIL or AE-ITU to Sham-operated
L-NIL or AE-ITU to rats prior to and during renal I/Rrats did not alter the total severity score in comparison
(Fig. 6). Administration of L-NIL or AE-ITU to Sham-to values obtained from Sham-operated rats that were
administered saline only (Fig. 5). operated rats did not alter plasma nitrite/nitrate levels
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Fig. 7. Immunohistochemical evidence of per-
oxynitrite formation in rat kidney following
I/R. (A) Kidney section from a Sham animal
(original magnification, OM, 
32) and (B)
from a rat subjected to I/R only (OM 
80).
In comparison, immunoreactivity of kidney
sections from rats subjected to I/R but admin-
istered (C ) L-NIL (3 mg/kg IV bolus followed
by 1 mg/kg/h IV infusion) or (D) AE-ITU
(1 mg/kg IV bolus followed by 1 mg/kg/h IV
infusion), was markedly reduced (OM 
80).
in comparison to values obtained from Sham-operated obtained from sham-operated rats, which were adminis-
tered L-NIL or AE-ITU (data not shown).rats that were administered saline only (Fig. 6).
Effect of L-NIL and AE-ITU on nitrotyrosine Effect of L-NIL and AE-ITU on cytokine-stimulated
nitric oxide production by primary cultures of ratformation during renal ischemia/reperfusion
proximal tubular cellsIn comparison to renal sections obtained from Sham-
operated rats which were administered saline only (Fig. Isolation of primary cultures of rat PT cells resulted
in confluent monolayers exhibiting typical ‘cobblestone’7A), immunohistochemical analysis of renal sections
obtained from rats subjected to renal I/R revealed posi- morphology associated with epithelial cells that did not
exhibit any evidence of fibroblast contamination. As dis-tive staining for nitrotyrosine (Fig. 7B). In contrast, sub-
stantially reduced staining was observed in the kidney cussed previously [22, 26], suspensions and cultures of rat
PT cells obtained using the isolation method describedsections obtained from rats, which were administered
L-NIL (Fig. 7C) or AE-ITU (Fig. 7D). No evidence of here have been previously characterized using phase-
contrast and electron-scanning microscopy, enzyme histo-staining for nitrotyrosine was observed in kidney sections
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hibition of NO production was observed when PT cells
were incubated with IFN- and LPS in the presence of in-
creasing concentrations of AE-ITU (0.001 to 1 mmol/L;
Fig. 8B).
DISCUSSION
There is good evidence from both in vivo and in vitro
studies that formation of NO plays an important role in
the pathophysiology of renal injury mediated by hypoxia
and I/R [18–22, 30, 31]. We demonstrate here, to our knowl-
edge for the first time, that administration of L-NIL and
AE-ITU, two relatively selective inhibitors of iNOS ac-
tivity, significantly reduces the renal dysfunction and in-
jury caused by I/R of the rat kidney. This conclusion is
supported by the following specific, key findings: In a rat
model of renal I/R, L-NIL and AE-ITU reduced the renal
I/R-mediated increases in (a) serum levels of urea and
creatinine (and improved creatinine clearance), (b) frac-
tional excretion of Na (FENa) and urinary concentrations
of NAG, (c) serum levels of AST and (d) plasma levels
of NO. L-NIL and AE-ITU also significantly reduced
the histological evidence of I/R-mediated tubular injury
and substantially reduced the immunohistochemical evi-
dence of nitrotyrosine expression. Finally, both L-NIL
and AE-ITU significantly inhibited the cytokine-stimu-
lated NO production by primary cultures of rat PT cells.
Ischemia/reperfusion of the kidney causes both glo-
merular and tubular dysfunction [36]. In this study, the
large increase in the serum concentrations of urea and
creatinine subsequent to I/R suggests significant impair-
ment of glomerular function, which was reflected by a
Fig. 8. Effect of L-NIL and AE-ITU on cytokine-stimulated NO2/NO3 significant reduction in creatinine clearance. Renal I/Rproduction by primary cultures of rat proximal tubule (PT) cells. Rat
also resulted in a large increase in FENa, suggesting sig-PT cells were incubated with incubation medium only (Untreated) or
with a combination of IFN- (100 IU/mL) and LPS (10 g/mL) for nificant impairment of tubular function. Renal I/R also
24 hours. PT cells were incubated with IFN- and LPS in the presence
caused an increase in urinary NAG concentrations, whichof increasing concentrations of (A) L-NIL (0.001 to 1 mmol/L) or (B)
AE-ITU (0.001 to 1 mmol/L). *P  0.05 vs. untreated group, P  can be regarded as a marker, possibly for tubular func-
0.05 vs. CK only group. tion, but definitely for tubular injury [37]. Evidence of
tubular injury also was supported by the histological scor-
ing of renal injury as there was marked tubular injury.
Renal I/R also produced significant increases in serumchemistry and the demonstration of PT specific transport
levels of AST, which can be regarded as a non-specificmechanisms (such as, d-glucose and anionic/cationic trans-
marker of extensive cellular disruption or necrosis [38]port). These studies have demonstrated that the cells iso-
and, as previously discussed [23, 27] was used in thislated using this technique are of PT origin and maintain
study as a marker of renal I/R.PT-specific properties throughout culture and during ex-
In this study, both L-NIL and AE-ITU produced sig-periments performed using primary cultures.
nificant reductions of renal dysfunction and injury medi-Incubation of rat PT cell cultures with IFN- and LPS
ated by I/R of this kidney. The degree of protection ofin combination for 24 hours produced a significant in-
the kidney against I/R-mediated renal dysfunction andcrease in NO production as determined by measurement
injury afforded by L-NIL and AE-ITU were similar. How-of nitrite/nitrate levels in incubation medium using the
ever, it is interesting to consider the mechanism(s) byGriess assay (Fig. 8). Incubation of PT cells with IFN-
which L-NIL and AE-ITU produce their beneficial effectsand LPS in the presence of increasing concentrations of
against renal dysfunction and injury mediated by I/R.L-NIL (0.001 to 1 mmol/L) resulted in a significant, con-
There is now good evidence that NO derived from NOScentration-dependent inhibition of NO production (Fig.
8A). A similar, significant, concentration-dependent in- plays an important role in renal function, both under nor-
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mal and pathophysiological conditions [11, 12]. High levels However, it was not clear whether these effects were due
to reduction of NO production from eNOS or iNOS [35].of NO produced by iNOS have been implicated in the
renal dysfunction/injury associated with either renal I/R This study compared the effects of L-NIL and AE-ITU,
which are both relatively selective inhibitors of iNOS[23] or during endotoxic and hemorrhagic shock [39, 40].
Several in vivo and in vitro investigations have demon- activity [32–34, 50, 51]. We demonstrate here that the
administration of L-NIL provides a significant reductionstrated that inhibition of iNOS expression (such as using
inhibitors of nuclear factor-B or tyrosine kinase activa- of the renal dysfunction and injury associated with I/R
of the rat kidney. In a recent study, L-NIL (3 mg/kg)tion), iNOS activity (such as using inhibitors of iNOS
activity), absence of iNOS itself (using iNOS/ mice), or reduced renal I/R injury and reduced peroxynitrite levels
in a rat model of bilateral renal occlusion (40 min I, 6 hscavenging of NO (for example, using hemoglobin) can
ameliorate or prevent NO-mediated renal injury [17–23], R) [31]. However, this effect was not observed at a higher
dose of L-NIL (10 mg/kg), suggesting a loss of isoformsuggesting that NO, generated by iNOS, contributes to
renal I/R injury. Furthermore, the generation and action selectivity that was reflected in the finding that nitrite/
nitrate levels in the plasma of sham-operated rats wereof ROS plays an important role in pathophysiology of
renal I/R [17, 18]. For instance, the combination of super- significantly reduced [31].
The beneficial role of AE-ITU in renal I/R has notoxide and NO leads to the formation of peroxynitrite,
which also contributes to renal I/R injury [31]. Taken been previously studied. Our current study demonstrates
that AE-ITU (at a dose comparable to that of L-NILtogether, along with formation of pro-inflammatory cyto-
kines [such as tumor necrosis factor- (TNF-), interleu- used in this study) provides significant beneficial actions
against the renal dysfunction and injury associated withkin (IL)-1, IL-6 or IL-8], the expression on endothelium
and neutrophils of adhesion molecules [such as vascular I/R of the rat kidney. AE-ITU is a relatively selective in-
hibitor of iNOS activity that has been used to investigatecell adhesion molecule-1 (VCAM-1), intercellular cell ad-
hesion molecule-1 (ICAM-1)], and the overproduction of the role of iNOS in LPS-mediated shock [52]. AE-ITU
belongs to the group of non-amino acid isothioureas,other vasoactive mediators [for example, eicosanoids via
cyclo-oxygenase-2 (COX-2)], formation of both ROS and which are potent and selective inhibitors of human nitric
oxide synthases [33]. Some members of this class of com-RNS contribute significantly to ischemic acute tubular
necrosis (ATN) leading to ARF [9, 11, 18, 30]. pound, such as ethyl-thiourea and isopropyl-thiourea,
are potent inhibitors of NOS, but without isoform selec-Pathophysiological conditions such as renal I/R and
endotoxemia cause the expression of iNOS mRNA and tivity [51], whereas others such as AE-ITU and S-methyl-
isothiourea (SMT) are relatively selective inhibitors ofprotein within the kidney [18, 30, 41, 42], increases eNOS
activity [43] but does not affect expression of nNOS [44]. iNOS activity compared to NG-substituted L-arginine an-
alogs [51]. It should, however, be noted that AE-ITUAlthough endogenous NO plays an important role in the
control of regional blood flow and intrarenal hemodynam- has several non-specific effects which are unrelated to
the ability of this compound to inhibit iNOS activity,ics (such as in supporting medullary reperfusion) [45], the
contribution of NO to changes in renal function following such as via ROS-scavenging activity or via reduction of
the expression of iNOS in Gram-positive shock [53, 54].injury is still relatively poorly understood. Early studies
suggested that inhibition of all isoforms of NOS by non- In this study, renal I/R caused an increase in the immu-
nological evidence of the generation of peroxynitrite thatselective NOS inhibitors by, for example, NG-monomethyl-
l-arginine (L-NMMA), causes a concomitant inhibition was identified as increased nitration of proteins. Genera-
tion of peroxynitrite causes renal injury via direct oxidantof eNOS activity, causing excessive vasoconstriction and
hence, exacerbates organ ischemia, microvascular throm- injury and protein tyrosine nitration [28, 29]. Respective
in vivo and in vitro studies have demonstrated that for-bosis and mortality [46]. This is supported by the find-
ing that a high dose of NG-nitro-l-arginine methyl ester mation of peroxynitrite contributes to the pathophysiol-
ogy of both renal I/R and hypoxia-reoxygenation injury,(L-NAME), a relatively selective inhibitor of eNOS ac-
tivity, reduces renal function in rats with or without endo- respectively [30, 31]. In vivo, peroxynitrite formation has
been demonstrated subsequent to renal I/R [31] and intoxemia [47] and augments the degree of kidney injury
(glomerular thrombosis) and reduces perfusion in a ro- vitro, hypoxia-reoxygenation injury of isolated PTs leads
to the generation of peroxynitrite [30]. Furthermore, per-dent model of endotoxic shock [47, 48]. Thus, the benefi-
cial hemodynamic effects of non-selective NOS inhibi- oxynitrite impairs the adhesion of the tubular membrane
to the basement membrane leading to the tubular ob-tors may well be due to inhibition of iNOS activity, while
the reported adverse effects may be due to inhibition of struction often observed in ARF [55]. Both L-NIL and
AE-ITU reduced evidence of peroxynitrite formationeNOS activity [49]. In contrast, inhibition of NOS activity
by L-NMMA in models of endotoxic shock attenuates that is most likely due to their inhibitory activity of iNOS
leading to reduced NO levels. It is highly likely that therenal dysfunction without influencing blood pressure or
total renal blood flow, and can increase urine output [35]. residual renal dysfunction and injury caused by I/R of the
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